跳转至内容
Merck
CN

68909

Supelco

番泻苷A

analytical standard

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C42H38O20
CAS号:
分子量:
862.74
Beilstein:
5723746
EC 号:
MDL编号:
UNSPSC代码:
85151701
PubChem化学物质编号:
NACRES:
NA.24

等级

analytical standard

质量水平

方案

≥96.0% (HPLC)

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

food and beverages

包装形式

neat

SMILES字符串

OC[C@H]1O[C@@H](Oc2cccc3[C@@H]([C@@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c7c(O)cc(cc47)C(O)=O)c8cc(cc(O)c8C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O

InChI

1S/C42H38O20/c43-11-23-31(47)35(51)37(53)41(61-23)59-21-5-1-3-15-25(17-7-13(39(55)56)9-19(45)27(17)33(49)29(15)21)26-16-4-2-6-22(60-42-38(54)36(52)32(48)24(12-44)62-42)30(16)34(50)28-18(26)8-14(40(57)58)10-20(28)46/h1-10,23-26,31-32,35-38,41-48,51-54H,11-12H2,(H,55,56)(H,57,58)/t23-,24-,25-,26-,31-,32-,35+,36+,37-,38-,41-,42?/m1/s1

InChI key

IPQVTOJGNYVQEO-GTCVFCFLSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

Sennoside A 是一种羟基蒽糖苷,通常存在于含有决明子叶的聚醚配方中,用于治疗便秘。

应用

有关合适仪器技术的更多信息,请参考产品′分析证书。如需进一步支持,请联系技术服务部门。

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Status of sennosides content in various Indian herbal formulations: method standardization by HPTLC
Aktar W, et al.
Bangladesh Journal of Pharmacology, 3, 64-68 (2008)
Acute hemorrhagic colitis following administration of sennosides for colon cleansing.
Burhan Ozdil et al.
The Annals of pharmacotherapy, 44(4), 770-771 (2010-03-25)
Acute generalized exanthematous pustulosis caused by sennoside in a patient with multiple myeloma.
K Sugita et al.
Journal of the European Academy of Dermatology and Venereology : JEADV, 22(4), 517-519 (2008-03-28)
Manuk N Manukyan et al.
Surgical laparoscopy, endoscopy & percutaneous techniques, 21(2), 90-93 (2011-04-08)
The aim of this study is to assess 2 different bowel-cleansing agents. The patients were prospectively randomized to 2 arms of sodium phosphate versus Sennoside A+B calcium preparation. Laboratory assessment, body weight, height, and vital signs were obtained at baseline
Philippa Helen Hawley et al.
Journal of palliative medicine, 11(4), 575-581 (2008-05-06)
Constipation is a common and distressing condition in patients with cancer, especially those taking opioid analgesics. Many institutions prevent and treat constipation with titrated laxatives, which is known as a bowel protocol. An effective and well-tolerated bowel protocol is a

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门